Arbor Pharmaceuticals is a specialty pharmaceutical company that markets more than 20 FDA-approved products in multiple therapeutic areas, including cardiovascular, neuroscience, pediatric, endocrinology and hospital markets. Arbor was acquired by Mercer alumnus Ed Schutter, BSPHARM ‘77, MBA, and two other investors in 2010. Since acquisition, the company has grown from less than $2 million in annual sales to more than $250 million. The company is led by a management team with extensive pharmaceutical industry experience in clinical development, medical and regulatory affairs, manufacturing, quality control and commercialization.
The company currently employs numerous M.D.s, Ph.D.s, Pharm.D.s, nurses and other scientists who work in medical, clinical or regulatory affairs, manufacturing, quality control, managed markets and commercial operations. Fellows will work primarily within the Arbor Pharmaceuticals medical department, led by Evan Scullin, M.D. Fellows will likely be involved in projects ranging from medical information, medical strategy, drug safety investigations, and research of new development or in-licensing opportunities. For more information regarding Arbor Pharmaceuticals or any of its products, please visit www.arborpharma.com.
Fellows will also have the opportunity to engage in research and teaching opportunities with faculty at Mercer University College of Pharmacy.